Catalent plans to expand production of J&J COVID-19 vaccine in Italy: WSJ

(Reuters) – Catalent Inc plans to expand its COVID-19 vaccine production in Europe that will enable it to make more doses of Johnson & Johnson’s shot, the Wall Street Journal reported here on Tuesday, citing people familiar with the matter.

The contract drug manufacturer will bring online a second J&J vaccine production line at its plant in Anagni, Italy, during the fourth quarter, the Journal reported.

Source: Read Full Article